Persistent URL of this record https://hdl.handle.net/1887/3256849
Documents
-
- Download
- gutjnl-2021-324834.full
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model
- All authors
- Kumar, S.; Schoonderwoerd, M.J.A.; Kroonen, J.S.; Graaf, I.J. de; Sluijter, M.; Ruano, D.; Gonzalez-Prieto, R.; Verlaan-de Vries, M.; Rip, J.; Arens, R.; Miranda, N.F.C.C. de; Hawinkels, L.J.A.C.; Hall, T. van; Vertegaal, A.C.O.
- Date
- 2022-01-23
- Journal
- Gut